glucagon has been researched along with Congenital Hyperinsulinism in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 11 (68.75) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, IY; Heo, YH; Kim, HH; Kim, JK; Lee, JS; Lee, SH; Shin, SH | 1 |
| Adzick, NS; Bhatti, TR; Boodhansingh, KE; Chen, P; De León, DD; Doliba, NM; Juliana, CA; Li, C; Li, M; Lu, M; Stanley, CA; Yuan, Y | 1 |
| Dionisi-Vici, C; Maiorana, A | 1 |
| Banerjee, I; Cosgrove, KE; Dunne, MJ; Nicholson, J; Salomon-Estebanez, M; Shah, P | 1 |
| Moran, MM; Neylon, OM; Nightingale, M; O'Connell, MA; Pellicano, A | 1 |
| Gannon, H; Hussain, K; Ponmani, C; Senniappan, S | 1 |
| Edwards, TM; Spatz, DL | 1 |
| Gilbert, C; Güemes, M; Hinchey, L; Hussain, K; Morgan, K; Shah, P; Silvera, S | 1 |
| Bhowmick, SK; Narayanaswamy, V; Rettig, KR | 1 |
| Ellard, S; Flanagan, SE; Gilbert, C; Hussain, K; Kapoor, RR; Moyo, Y; Padidela, R | 1 |
| Empting, S; Holl, R; Ludwig, A; Marquard, J; Meissner, T; Mohnike, K; Ziegenhorn, K | 1 |
| Brusgaard, K; Christesen, HT; Hussain, K | 1 |
| Calabria, AC; De León, DD; Gallagher, PR; Li, C; Stanley, CA | 1 |
| Krans, HM | 1 |
| Aynsley-Green, A; Hussain, K; Stanley, CA | 1 |
| Blankenstein, O; Grimberg, A; Hardy, OT; Mohnike, K; Pfuetzner, A; Pötzsch, S; Schober, E; Steiner, S; van Waarde, WM | 1 |
4 review(s) available for glucagon and Congenital Hyperinsulinism
| Article | Year |
|---|---|
Hyperinsulinemic hypoglycemia: clinical, molecular and therapeutical novelties.
Topics: Adenosine Triphosphate; Animals; Child; Child, Preschool; Congenital Hyperinsulinism; Diet, Ketogenic; Galactose; Glucagon; Humans; Hypoglycemia; Infant; Insulin; Insulin Secretion; Insulin-Secreting Cells; Mice; Nervous System Diseases; Peptide Fragments; Potassium Channels; Receptor, Insulin; Sirolimus; Somatostatin; Treatment Outcome | 2017 |
Therapies and outcomes of congenital hyperinsulinism-induced hypoglycaemia.
Topics: Antihypertensive Agents; Congenital Hyperinsulinism; Diazoxide; Gastrointestinal Agents; Glucagon; Humans; Hypoglycemia; Pancreatectomy; Potassium Channels, Inwardly Rectifying; Precision Medicine; Sulfonylurea Receptors; Treatment Outcome | 2019 |
Congenital hyperinsulinism: exclusive human milk and breastfeeding.
Topics: Breast Feeding; Congenital Hyperinsulinism; Diazoxide; Female; Fluid Therapy; Food, Fortified; Gastrointestinal Agents; Glucagon; Glucose; Humans; Hypoglycemia; Infant, Newborn; Milk, Human; Octreotide; Pancreatectomy; Sweetening Agents | 2014 |
Medications used in the treatment of hypoglycemia due to congenital hyperinsulinism of infancy (HI).
Topics: Congenital Hyperinsulinism; Diazoxide; Gastrointestinal Agents; Glucagon; Humans; Hypoglycemia; Infant; Nifedipine; Octreotide; Vasodilator Agents | 2004 |
2 trial(s) available for glucagon and Congenital Hyperinsulinism
| Article | Year |
|---|---|
GLP-1 receptor antagonist exendin-(9-39) elevates fasting blood glucose levels in congenital hyperinsulinism owing to inactivating mutations in the ATP-sensitive K+ channel.
Topics: Adolescent; Adult; Blood Glucose; Congenital Hyperinsulinism; Cross-Over Studies; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Infant, Newborn; Insulin; Insulin Secretion; Islets of Langerhans; KATP Channels; Male; Mutation; Peptide Fragments; Pilot Projects; Receptors, Glucagon | 2012 |
Long-term non-surgical therapy of severe persistent congenital hyperinsulinism with glucagon.
Topics: Blood Glucose; Brain Diseases, Metabolic; Congenital Hyperinsulinism; Female; Gastrointestinal Agents; Glucagon; Glycogen; Humans; Hypoglycemia; Infant, Newborn; Male; Octreotide; Pancreatectomy; Retrospective Studies | 2008 |
10 other study(ies) available for glucagon and Congenital Hyperinsulinism
| Article | Year |
|---|---|
A novel glucagon analog with an extended half-life, HM15136, normalizes glucose levels in rodent models of congenital hyperinsulinism.
Topics: Animals; Blood Glucose; Congenital Hyperinsulinism; Glucagon; Half-Life; Humans; Hyperinsulinism; Immunoglobulin Fc Fragments; Insulin; Mice; Polyethylene Glycols; Rats; Receptors, Glucagon; Rodentia | 2022 |
Phenotypic Characterization of Congenital Hyperinsulinism Due to Novel Activating Glucokinase Mutations.
Topics: Child; Congenital Hyperinsulinism; Glucagon; Glucokinase; Glucose; Humans; Hyperinsulinism; Mutation; Phenotype | 2023 |
Successful subcutaneous glucagon use for persistent hypoglycaemia in congenital hyperinsulinism.
Topics: Congenital Hyperinsulinism; Glucagon; Humans; Hypoglycemia; Infant, Newborn; Male; Pancreas; Pancreatectomy | 2013 |
Paradoxical hypoglycaemia associated with diazoxide therapy for hyperinsulinaemic hypoglycaemia.
Topics: Congenital Hyperinsulinism; Diazoxide; Female; Glucagon; Glucose; Humans; Hypoglycemia; Infant; Octreotide; Sulfonylurea Receptors | 2013 |
Assessment of Nifedipine Therapy in Hyperinsulinemic Hypoglycemia due to Mutations in the ABCC8 Gene.
Topics: Calcium Channel Blockers; Child, Preschool; Cohort Studies; Congenital Hyperinsulinism; Diazoxide; Drug Therapy, Combination; Female; Gastrointestinal Agents; Glucagon; Humans; Infant; Male; Nifedipine; Octreotide; Prospective Studies; Starch; Sulfonylurea Receptors; Treatment Outcome | 2017 |
A lethargic neonate and an infant with seizure.
Topics: Blood Glucose; Congenital Hyperinsulinism; Diazoxide; Glucagon; Glucose; Humans; Hypoglycemia; Infant; Infant, Newborn; Lethargy; Male; Physical Examination; Respiratory Distress Syndrome, Newborn; Seizures; Vasodilator Agents | 2010 |
Focal congenital hyperinsulinism in a patient with septo-optic dysplasia.
Topics: 3-Hydroxybutyric Acid; Blood Glucose; C-Peptide; Congenital Hyperinsulinism; Glucagon; Glucose; Humans; Hydrocortisone; Hypopituitarism; Infant; Insulin; Loss of Heterozygosity; Male; Pancreas; Pituitary Hormones; Septo-Optic Dysplasia | 2010 |
Glucose metabolism and neurological outcome in congenital hyperinsulinism.
Topics: Adolescent; Case-Control Studies; Child; Child, Preschool; Congenital Hyperinsulinism; Developmental Disabilities; Diabetes Mellitus; Female; Gastrointestinal Agents; Germany; Glucagon; Humans; Infant; Infant, Newborn; Language Development Disorders; Male; Octreotide; Pancreatectomy; Prospective Studies; Psychomotor Disorders; Treatment Outcome | 2011 |
Recurrent spontaneous hypoglycaemia causes loss of neurogenic and neuroglycopaenic signs in infants with congenital hyperinsulinism.
Topics: Blood Glucose; Congenital Hyperinsulinism; Epinephrine; Fasting; Female; Glucagon; Glucose Clamp Technique; Humans; Hypoglycemia; Infant; Insulin; Male; Norepinephrine | 2012 |
[Congenital hyperinsulinism in 15 infants, 1981-1999; experiences and new insights].
Topics: Congenital Hyperinsulinism; Erythema; Glucagon; Humans; Infant, Newborn | 2004 |